Share

February 12, 2013; 80 (7) Article

Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD

Daan C. Velseboer, Mark Broeders, Bart Post, Nan van Geloven, Johannes D. Speelman, Ben Schmand, Rob J. de Haan, Rob M.A. de Bie, on behalf of the CARPA Study Group
First published January 23, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318281cc99
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
513

Share

Article Information

vol. 80 no. 7 627-633
DOI: 
https://doi.org/10.1212/WNL.0b013e318281cc99
PubMed: 
23345637
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 13, 2012
  • Accepted October 11, 2012
  • First Published January 23, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Daan C. Velseboer, MD,
    2. Mark Broeders, MSc,
    3. Bart Post, MD, PhD,
    4. Nan van Geloven, MSc,
    5. Johannes D. Speelman, MD, PhD,
    6. Ben Schmand, PhD,
    7. Rob J. de Haan, PhD,
    8. Rob M.A. de Bie, MD, PhD;
    9. on behalf of the CARPA Study Group
  1. Daan C. Velseboer, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mark Broeders, MSc,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Bart Post, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Nan van Geloven, MSc,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Johannes D. Speelman, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1. Medtronic ltd, Minneapolis, concerning DBS

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Medtronic Ltd Minneapolis

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Ben Schmand, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Abbott, partial funding for travel and conference attendance.

    Editorial Boards:

    1. Tijdschrift voor Neuropsychologie, 2005 - present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Rob J. de Haan, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Rob M.A. de Bie, MD, PhD;
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Received funding for a trip from Medtronic (2010) and fora trip from Abbot (2010).

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Received an unrestricted fellowship grant from Medtronic.Received a reserach grant from GE Health

    Research Support, Government Entities:

    1. Received a research grant from ZonMw Doelmatigheid(171102018).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Received research grants from the Parkinson Vereniging(Patient's Society), the Prinses Beatrix Fonds (WAR08-02), Internationaal Parkinson Fonds, Michael J FoxFoundation, Kinetics Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. on behalf of the CARPA Study Group
  1. From the Department of Neurology (D.C.V., J.D.S., B.S., R.M.A.d.B.), Clinical Research Unit (N.v.G., R.J.d.H.), Academic Medical Center, and Department of Brain and Cognition (M.B., B.S.), University of Amsterdam; and Department of Neurology (B.P.), Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
  1. Correspondence to Dr. Velseboer: d.c.velseboer{at}amc.uva.nl
View Full Text

Article usage

Article usage: January 2013 to April 2022

AbstractFullPdfSource
Jan 2013240024Highwire
Feb 2013184065132Highwire
Mar 20132922529Highwire
Apr 20132032317Highwire
May 20131221113Highwire
Jun 20131011513Highwire
Jul 2013751111Highwire
Aug 20135657Highwire
Sep 201362108Highwire
Oct 2013682030Highwire
Nov 201360178Highwire
Dec 2013322510Highwire
Jan 20146935Highwire
Feb 20143491Highwire
Mar 2014621513Highwire
Apr 20145664Highwire
May 20142422Highwire
Jun 20145865Highwire
Jul 20144074Highwire
Aug 20144566Highwire
Sep 20143435Highwire
Oct 2014671010Highwire
Nov 20142761Highwire
Dec 201421239Highwire
Jan 201540128Highwire
Feb 201537123Highwire
Mar 20153665Highwire
Apr 20152800Highwire
May 20151423Highwire
Jun 20152921Highwire
Jul 20153201Highwire
Aug 20152120Highwire
Sep 20151000Highwire
Oct 20153553Highwire
Nov 20154365Highwire
Dec 20151020Highwire
Jan 20162164Highwire
Feb 20162911Highwire
Mar 20162367Highwire
Apr 20162421Highwire
May 20161012Highwire
Jun 20161657Highwire
Jul 20162410Highwire
Aug 20162033Highwire
Sep 20161832Highwire
Oct 20162824Highwire
Nov 20161800Highwire
Dec 20161756Highwire
Jan 20171830Highwire
Feb 20172101Highwire
Mar 20173140Highwire
Apr 20171713Highwire
May 20171911Highwire
Jun 2017810Highwire
Jul 2017410Highwire
Aug 2017721Highwire
Sep 20171000Highwire
Oct 20172024Highwire
Nov 20171100Highwire
Dec 20171010Highwire
Jan 20182142Highwire
Feb 20181500Highwire
Mar 20182202Highwire
Apr 20183241Highwire
May 20182632Highwire
Jun 20182410Highwire
Jul 20183511Highwire
Aug 20181832Highwire
Sep 20182510Highwire
Oct 20182795Highwire
Nov 20184633Highwire
Dec 20182701Highwire
Jan 20192211Highwire
Feb 20193000Highwire
Mar 20194302Highwire
Apr 20195211Highwire
May 20191851Highwire
Jun 20192322Highwire
Jul 20192111Highwire
Aug 20191801Highwire
Sep 20191412Highwire
Oct 20191501Highwire
Nov 20191433Highwire
Dec 20191523Highwire
Jan 20201531Highwire
Feb 20201800Highwire
Mar 20201801Highwire
Apr 20202601Highwire
May 20202701Highwire
Jun 20201310Highwire
Jul 2020500Highwire
Aug 20202420Highwire
Sep 2020711Highwire
Oct 20202034Highwire
Nov 20202511Highwire
Dec 20201333Highwire
Jan 20211702Highwire
Feb 20213712Highwire
Mar 20213600Highwire
Apr 20212400Highwire
May 20212510Highwire
Jun 20211433Highwire
Jul 20213600Highwire
Aug 20211000Highwire
Sep 20211301Highwire
Oct 20214700Highwire
Nov 20213611Highwire
Dec 20212601Highwire
Jan 20222011Highwire
Feb 20222522Highwire
Mar 20223503Highwire
Apr 20224414Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me